Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade ; volume:8 ; number:1 ; day:2 ; month:1 ; year:2024 ; pages:1-3 ; date:12.2024
npj precision oncology ; 8, Heft 1 (2.1.2024), 1-3, 12.2024
- Creator
-
Spurr, Liam F.
Pitroda, Sean P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-023-00492-8
- URN
-
urn:nbn:de:101:1-2024031508340662600420
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spurr, Liam F.
- Pitroda, Sean P.
- SpringerLink (Online service)
Other Objects (12)
CD74 is a potential biomarker predicting the response to immune checkpoint blockade
Meiotic spindle assembly checkpoint and aneuploidy in males versus females
Aneuploidy
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Tumor aneuploidy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Aneuploidy : 21 tables
Activation of phagocytosis by immune checkpoint blockade
Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicants
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
CD74 is a potential biomarker predicting the response to immune checkpoint blockade
Meiotic spindle assembly checkpoint and aneuploidy in males versus females
Aneuploidy
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Tumor aneuploidy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Aneuploidy : 21 tables
Activation of phagocytosis by immune checkpoint blockade
Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicants
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
CD74 is a potential biomarker predicting the response to immune checkpoint blockade
Meiotic spindle assembly checkpoint and aneuploidy in males versus females
Aneuploidy
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
Tumor aneuploidy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features
Aneuploidy : 21 tables
Activation of phagocytosis by immune checkpoint blockade
Aneuploidy: a common and early evidence-based biomarker for carcinogens and reproductive toxicants